Integrated
Test: One of the most important tools for prenatal care.
Why
is age taken into account?
The
chances of a woman having a baby with Down Syndrome increases
with her age. For this reason, age is one of the important
factors in calculating the risk of a Down Syndrome pregnancy.
An older woman is more likely to screen as positive and
be offered a diagnostic test. This is shown in the table
below.
Maternal Age Group (years)
|
Probability of a screen-positive
result
|
Proportion of Down Syndrome
pregnancies detected (%)
|
15 - 34
|
1 in 130
|
81%
|
35 and over
|
1 in 25
|
92%
|
All
|
2 in 100
|
90%
|
What
is the Integrated Test?
The
Integrated Test is a blood screening for pregnant women.
The test identifies women who are at high-risk for having
a baby with Down Syndrome, open neural tube defects and
other birth defects. The Integrated Test is performed
in two stages:
The first stage is performed between the 8th and the
13th week of pregnancy and involves:
- An ultrasound scan examination to determine the
gestational age of the pregnancy
- A blood sample to measure the concentration of a
protein called pregnancy associated plasma protein-A
(PAPP-A)
- An appointment for an ultrasound nuchal
translucency measurement
The second stage is performed between the 15th and
22nd week of pregnancy. It involves another blood sample
to measure the concentration of the following four substances:
- Alpha-fetoprotein (AFP)
- Unconjugated estriol (uE3)
- Human chorionic gonadotropin (ß-hCG)
- Inhibin-A (inhibin)
The measurements from the first and second stages are
integrated into a single screening result. The nuchal
translucency measurement and the levels of the five markers
in your blood are used, together with your age, to estimate
your risk of having a Down Syndrome pregnancy.
Why
is there another test at the second stage?
By
using information from both stages, the test is safer
and more effective than results from the first stage
alone. The Integrated Test results will distinguish between
affected and unaffected pregnancies more effectively,
thereby reducing the chance that a Down Syndrome pregnancy
is missed. It also reduces the likelihood that you will
need an invasive diagnostic test, such as amniocentesis.
What
is Down Syndrome?
Down
Syndrome is the most common cause of severe mental disability
and is often associated with physical problems, such
as heart defects or difficulty with sight and hearing.
It involves a pattern of birth defects and mental retardation,
occurring in about one in every 700 births. Down Syndrome
is a disorder in which an extra chromosome number 21
is present in the cells of the developing fetus. It occurs
unexpectedly and is usually not inherited. About nine
of ten babies with Down Syndrome will survive their first
year, and nearly half of these will reach age 60. It
is not possible to assess the degree of handicap before
the baby is born.
What
are neural tube defects?
Neural
tube defects are birth defects that affect the brain
and the spine. One or two babies out of 1,000 are born
with a neural tube defect. These defects involve failure
of bony tissue to close properly. The two most common
defects are spina bifida and anencephaly.
Spina bifida usually causes some degree of paralysis
from the waist down and may interfere with bowel and
bladder control. It often leads to a condition called
hydrocephalus (water on the brain) and can sometimes
cause mental retardation. Almost one-third of the babies
born with open spina bifida will not survive past age
five. Anencephaly is a very serious defect that occurs
when a baby’s brain and skull fail to develop properly.
Babies born with this condition do not survive more than
a few days.
Can
other abnormalities be identified?
Yes.
The risk of other disorders can be identified. Trisomy
18 Syndrome, also known as Edwards’ Syndrome, is
a rare and usually fatal disorder caused by the presence
of an extra chromosome number 18 in the cells of the
developing baby. The risk of Trisomy 18 Syndrome is reported
only when the risk is high.
What
does a negative screen result mean?
A
negative screen result means that you are not at high
risk of having a baby with Down Syndrome or a neural
tube defect, but it does not rule out the possibility
of a pregnancy with either of these abnormalities.
What
does a positive screen result mean?
A
positive screen result means that you are in a higher
risk group for having a baby with Down Syndrome. The
risk of Down Syndrome in your pregnancy is 1 in 270,
and you will be offered a diagnostic amniocentesis. About
two in every 100 women screened will be in this risk
group. Most women who screen as positive, however, do
not have a Down Syndrome pregnancy.
A positive screen result can also mean that you are
at increased risk of having a baby with an open neural
tube defect. If your result is in this group, you will
be offered an ultrasound scan examination at the 18th
to 20th week of pregnancy, and possibly, an amniocentesis.
What
is an Amniocentesis?
Amniocentesis
is a medical procedure in which a small amount of fluid
is withdrawn from the sac surrounding the fetus in the
uterus. This fluid sample is used to diagnose the existence
of chromosomal disorders, such as Down Syndrome and Trisomy
18 Syndrome, as well as open neural tube defects, such
as spina bifida. Amniocentesis is an invasive procedure,
meaning that there is a small risk of miscarriage (less
than 1 in 200) associated with it.
No test can guarantee that your baby will be free of
all birth defects. If, however, the amniocentesis result
is negative, it will almost certainly rule out the presence
of Down Syndrome or other chromosomal abnormalities.
